Meta-analysis of the efficacy and safety of nucleotide/nucleoside analog monotherapy for hepatitis B virus-associated glomerulonephritis.

CONCLUSIONS: HBV-GN proteinuria remission with elevated serum albumin, decreased HBV replication, and improved HBeAg clearance could be achieved using NA monotherapy. Furthermore, NA monotherapy may protect renal function in HBV-GN patients by preventing Scr elevation. PMID: 26636326 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26636326?dopt=Abstract

Source: Clinical Nephrology - December 4, 2015 Category: Urology & Nephrology Authors: Wang WN, Wu MY, Ma FZ, Sun T, Xu ZG Tags: Clin Nephrol Source Type: research